HDAC6 also can deacetylate β-catenin at lysine 49 and inhibit β-catenin phosphorylation at serine 45, promote epidermal growth factor–induced β-catenin nuclear localization, and lead to tumor cell proliferation (51). This evidence concerns the gene HDAC6 and neoplasm.